Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1993 Sep;70(3):233–240. doi: 10.1136/hrt.70.3.233

Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.

R Stevenson 1, K Ranjadayalan 1, P Wilkinson 1, B Marchant 1, A D Timmis 1
PMCID: PMC1025302  PMID: 8398493

Abstract

OBJECTIVES--To evaluate the role of Holter ST monitoring for identifying patients at risk of recurrent ischaemic events after acute myocardial infarction treated by thrombolysis. BACKGROUND--The natural history of myocardial infarction has changed with the introduction of thrombolytic treatment. There is now a lower mortality but a higher incidence of recurrent thrombotic events (reinfarction, unstable angina). Preliminary evidence indicates that Holter ST monitoring may be of prognostic value in patients with acute myocardial infarction, but there are limited data available in patients treated by thrombolysis. METHODS--Prospective observational study of 256 consecutive patients who presented with acute myocardial infarction treated by thrombolysis. All underwent 48 hour Holter ST monitoring early after thrombolysis (mean 83, range 48-180 hours) and were followed up for eight (range three to 12) months. RESULTS--Recurrent ischaemic events occurred in 45 patients (fatal reinfarction 17, non-fatal reinfarction 12, unstable angina 16). Also four patients died as a result of progressive heart failure, and a further 15 patients required revascularisation. Analysis of the Holter data showed that 32% of patients had at least one episode of isolated ST depression (> or = 0.1 mV) and 41% either ST depression or elevation (> or = 0.2 mV). Ischaemic episodes were silent in 95% of cases. Event free survival analysis showed a significant association between Holter findings and recurrent ischaemic events (ST depression: p = 0.009; ST depression or elevation: p = 0.002). The association remained significant when the end point was restricted to fatal or non-fatal reinfarction (ST depression: p = 0.005; ST depression or elevation p = 0.001), the period of greatest risk for patients with an abnormal recording occurred early after investigation. An abnormal Holter recording identified patients at risk of early (within 30 days) reinfarction with 79% sensitivity and 60% specificity. Although positive predictive accuracy was low (11%), a normal Holter recording was associated with 98% negative predictive accuracy. CONCLUSIONS--In patients treated by thrombolysis, ST change on Holter monitoring may be useful for identifying patients at increased risk of recurrent ischaemic events, and in particular early reinfarction.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonaduce D., Petretta M., Lanzillo T., Vitagliano G., Bianchi V., Conforti G., Morgano G., Arrichiello P. Prevalence and prognostic significance of silent myocardial ischaemia detected by exercise test and continuous ECG monitoring after acute myocardial infarction. Eur Heart J. 1991 Feb;12(2):186–193. doi: 10.1093/oxfordjournals.eurheartj.a059867. [DOI] [PubMed] [Google Scholar]
  2. Currie P., Saltissi S. Transient ischaemia after acute myocardial infarction: relationship to exercise ischaemia. Eur Heart J. 1991 Mar;12(3):395–400. doi: 10.1093/oxfordjournals.eurheartj.a059907. [DOI] [PubMed] [Google Scholar]
  3. Currie P., Saltissi S. Transient myocardial ischaemia after acute myocardial infarction. Br Heart J. 1990 Nov;64(5):299–303. doi: 10.1136/hrt.64.5.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dellborg M., Topol E. J., Swedberg K. Dynamic QRS complex and ST segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 1991 Oct;122(4 Pt 1):943–948. doi: 10.1016/0002-8703(91)90455-q. [DOI] [PubMed] [Google Scholar]
  5. Ellis S. G., Topol E. J., George B. S., Kereiakes D. J., Debowey D., Sigmon K. N., Pickel A., Lee K. L., Califf R. M. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation. 1989 Nov;80(5):1159–1165. doi: 10.1161/01.cir.80.5.1159. [DOI] [PubMed] [Google Scholar]
  6. Feit F., Mueller H. S., Braunwald E., Ross R., Hodges M., Herman M. V., Knatterud G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group. J Am Coll Cardiol. 1990 Dec;16(7):1529–1534. doi: 10.1016/0735-1097(90)90295-z. [DOI] [PubMed] [Google Scholar]
  7. Fitzgerald D. J., Catella F., Roy L., FitzGerald G. A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988 Jan;77(1):142–150. doi: 10.1161/01.cir.77.1.142. [DOI] [PubMed] [Google Scholar]
  8. Fox K. M. Silent ischaemia: clinical implications in 1988. Br Heart J. 1988 Nov;60(5):363–366. doi: 10.1136/hrt.60.5.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fuller C. M., Raizner A. E., Verani M. S., Nahormek P. A., Chahine R. A., McEntee C. W., Miller R. R. Early post-myocardial infarction treadmill stress testing. An accurate predictor of multivessel coronary disease and subsequent cardiac events. Ann Intern Med. 1981 Jun;94(6):734–739. doi: 10.7326/0003-4819-94-6-734. [DOI] [PubMed] [Google Scholar]
  10. Gottlieb S. O., Gottlieb S. H., Achuff S. C., Baumgardner R., Mellits E. D., Weisfeldt M. L., Gerstenblith G. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA. 1988 Feb 19;259(7):1030–1035. [PubMed] [Google Scholar]
  11. Gottlieb S. O., Weisfeldt M. L., Ouyang P., Mellits E. D., Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986 May 8;314(19):1214–1219. doi: 10.1056/NEJM198605083141903. [DOI] [PubMed] [Google Scholar]
  12. Gottlieb S. O., Weisfeldt M. L., Ouyang P., Mellits E. D., Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol. 1987 Oct;10(4):756–760. doi: 10.1016/s0735-1097(87)80267-x. [DOI] [PubMed] [Google Scholar]
  13. Harrison D. G., Ferguson D. W., Collins S. M., Skorton D. J., Ericksen E. E., Kioschos J. M., Marcus M. L., White C. W. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation. 1984 May;69(5):991–999. doi: 10.1161/01.cir.69.5.991. [DOI] [PubMed] [Google Scholar]
  14. Jespersen C. M., Kassis E., Edeling C. J., Madsen J. K. The prognostic value of maximal exercise testing soon after first myocardial infarction. Eur Heart J. 1985 Sep;6(9):769–772. doi: 10.1093/oxfordjournals.eurheartj.a061939. [DOI] [PubMed] [Google Scholar]
  15. Johnson S. M., Mauritson D. R., Winniford M. D., Willerson J. T., Firth B. G., Cary J. R., Hillis L. D. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J. 1982 Jan;103(1):4–12. doi: 10.1016/0002-8703(82)90522-1. [DOI] [PubMed] [Google Scholar]
  16. Kwon K., Freedman S. B., Wilcox I., Allman K., Madden A., Carter G. S., Harris P. J. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. Am J Cardiol. 1991 Jan 15;67(2):109–115. doi: 10.1016/0002-9149(91)90430-s. [DOI] [PubMed] [Google Scholar]
  17. Langer A., Minkowitz J., Dorian P., Casella L., Harris L., Morgan C. D., Armstrong P. W. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol. 1992 Nov 15;20(6):1313–1317. doi: 10.1016/0735-1097(92)90242-f. [DOI] [PubMed] [Google Scholar]
  18. Larsson H., Jonasson T., Ringqvist I., Fellenius C., Wallentin L. Diagnostic and prognostic importance of ST recording after an episode of unstable angina or non-Q-wave myocardial infarction. Eur Heart J. 1992 Feb;13(2):207–212. doi: 10.1093/oxfordjournals.eurheartj.a060148. [DOI] [PubMed] [Google Scholar]
  19. Lavie C. J., Gibbons R. J., Zinsmeister A. R., Gersh B. J. Interpreting results of exercise studies after acute myocardial infarction altered by thrombolytic therapy, coronary angioplasty or bypass. Am J Cardiol. 1991 Jan 15;67(2):116–120. doi: 10.1016/0002-9149(91)90431-j. [DOI] [PubMed] [Google Scholar]
  20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  21. Ohman E. M., Califf R. M., Topol E. J., Candela R., Abbottsmith C., Ellis S., Sigmon K. N., Kereiakes D., George B., Stack R. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation. 1990 Sep;82(3):781–791. doi: 10.1161/01.cir.82.3.781. [DOI] [PubMed] [Google Scholar]
  22. Ouyang P., Chandra N. C., Gottlieb S. O. Frequency and importance of silent myocardial ischemia identified with ambulatory electrocardiographic monitoring in the early in-hospital period after acute myocardial infarction. Am J Cardiol. 1990 Feb 1;65(5):267–270. doi: 10.1016/0002-9149(90)90285-9. [DOI] [PubMed] [Google Scholar]
  23. Petretta M., Bonaduce D., Bianchi V., Vitagliano G., Conforti G., Rotondi F., Themistoclakis S., Morgano G. Characterization and prognostic significance of silent myocardial ischemia on predischarge electrocardiographic monitoring in unselected patients with myocardial infarction. Am J Cardiol. 1992 Mar 1;69(6):579–583. doi: 10.1016/0002-9149(92)90145-o. [DOI] [PubMed] [Google Scholar]
  24. Ruberman W., Crow R., Rosenberg C. R., Rautaharju P. M., Shore R. E., Pasternack B. S. Intermittent ST depression and mortality after myocardial infarction. Circulation. 1992 Apr;85(4):1440–1446. doi: 10.1161/01.cir.85.4.1440. [DOI] [PubMed] [Google Scholar]
  25. Simoons M. L., Serruys P. W., vd Brand M., Bär F., de Zwaan C., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 Sep 14;2(8455):578–582. doi: 10.1016/s0140-6736(85)90584-7. [DOI] [PubMed] [Google Scholar]
  26. Simoons M. L., Vos J., Tijssen J. G., Vermeer F., Verheugt F. W., Krauss X. H., Cats V. M. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol. 1989 Dec;14(7):1609–1615. doi: 10.1016/0735-1097(89)90003-x. [DOI] [PubMed] [Google Scholar]
  27. Tzivoni D., Gavish A., Zin D., Gottlieb S., Moriel M., Keren A., Banai S., Stern S. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):661–664. doi: 10.1016/0002-9149(88)91198-8. [DOI] [PubMed] [Google Scholar]
  28. Williams D. O., Borer J., Braunwald E., Chesebro J. H., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Knatterud G., Ludbrook P. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation. 1986 Feb;73(2):338–346. doi: 10.1161/01.cir.73.2.338. [DOI] [PubMed] [Google Scholar]
  29. Williams D. O., Braunwald E., Knatterud G., Babb J., Bresnahan J., Greenberg M. A., Raizner A., Wasserman A., Robertson T., Ross R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation. 1992 Feb;85(2):533–542. doi: 10.1161/01.cir.85.2.533. [DOI] [PubMed] [Google Scholar]
  30. de Belder M. A., Pumphrey C. W., Skehan J. D., Rimington H., al Wakeel B., Evans S. J., Rothman M., Mills P. G. Relative power of clinical, exercise test, and angiographic variables in predicting clinical outcome after myocardial infarction: the Newham and Tower Hamlets study. Br Heart J. 1988 Nov;60(5):377–389. doi: 10.1136/hrt.60.5.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. von Arnim T., Höfling B., Schreiber M. Characteristics of episodes of ST elevation or ST depression during ambulatory monitoring in patients subsequently undergoing coronary angiography. Br Heart J. 1985 Nov;54(5):484–488. doi: 10.1136/hrt.54.5.484. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES